ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000

March 29, 1985

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

January 2, 1976